SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Marina Nikolić, Djuro Macut, Ana Djordjevic, Nataša Veličković, Nataša Nestorović, Biljana Bursać, Ivana Božić Antić, Jelica Bjekić Macut, Gordana Matić, Danijela Vojnović Milutinović, Possible involvement of glucocorticoids in 5α-dihydrotestosterone-induced PCOS-like metabolic disturbances in the rat visceral adipose tissue, Molecular and Cellular Endocrinology, 2015, 399, 22

    CrossRef

  2. 2
    Sanja Kovačević, Jelena Nestorov, Gordana Matić, Ivana Elaković, Dietary fructose-related adiposity and glucocorticoid receptor function in visceral adipose tissue of female rats, European Journal of Nutrition, 2014, 53, 6, 1409

    CrossRef

  3. 3
    Giacomo Tirabassi, Marco Boscaro, Giorgio Arnaldi, Harmful effects of functional hypercortisolism: a working hypothesis, Endocrine, 2014, 46, 3, 370

    CrossRef

  4. 4
    Seong-Su Moon, Young-Sil Lee, Jung-Guk Kim, In-Kyu Lee, Association of 11β-hydroxysteroid dehydrogenase type 1 gene polymorphisms with serum alanine aminotransferase activity, Diabetes Research and Clinical Practice, 2013, 99, 3, 343

    CrossRef

  5. 5
    Hui Ping Yaw, Effects of Glycyrrhetic Acid (GE) on Some Gluconeogenic Enzymes, Lipoprotein Lipase and Peroxisome Proliferator-Activated Receptors Alpha and Gamma, The Open Bioactive Compounds Journal, 2013, 4, 1, 14

    CrossRef

  6. 6
    L. Fardet, Effets indésirables métaboliques et cardiovasculaires des corticothérapies systémiques, La Revue de Médecine Interne, 2013, 34, 5, 303

    CrossRef

  7. 7
    Biljana N. Bursać, Ana D. Djordjevic, Ana D. Vasiljević, Danijela D. Vojnović Milutinović, Nataša A. Veličković, Nataša M. Nestorović, Gordana M. Matić, Fructose consumption enhances glucocorticoid action in rat visceral adipose tissue, The Journal of Nutritional Biochemistry, 2013, 24, 6, 1166

    CrossRef

  8. 8
    Josefine Lindroos, Julia Husa, Gerfried Mitterer, Arvand Haschemi, Sabine Rauscher, Robert Haas, Marion Gröger, Robert Loewe, Norbert Kohrgruber, Klaus F. Schrögendorfer, Gerhard Prager, Harald Beck, J. Andrew Pospisilik, Maximilian Zeyda, Thomas M. Stulnig, Wolfgang Patsch, Oswald Wagner, Harald Esterbauer, Martin Bilban, Human but Not Mouse Adipogenesis Is Critically Dependent on LMO3, Cell Metabolism, 2013, 18, 1, 62

    CrossRef

  9. 9
    P. Barat, J. Brossaud, A. Lacoste, V. Vautier, F. Nacka, M.-P. Moisan, J.-B. Corcuff, Nocturnal activity of 11β-hydroxy steroid dehydrogenase type 1 is increased in type 1 diabetic children, Diabetes & Metabolism, 2013, 39, 2, 163

    CrossRef

  10. 10
    C. Guo, C. Li, L. Myatt, P. W. Nathanielsz, K. Sun, Sexually Dimorphic Effects of Maternal Nutrient Reduction on Expression of Genes Regulating Cortisol Metabolism in Fetal Baboon Adipose and Liver Tissues, Diabetes, 2013, 62, 4, 1175

    CrossRef

  11. 11
    John M. Busillo, John A. Cidlowski, The five Rs of glucocorticoid action during inflammation: ready, reinforce, repress, resolve, and restore, Trends in Endocrinology & Metabolism, 2013, 24, 3, 109

    CrossRef

  12. 12
    C. D. Pereira, I. Azevedo, R. Monteiro, M. J. Martins, 11β-Hydroxysteroid dehydrogenase type 1: relevance of its modulation in the pathophysiology of obesity, the metabolic syndrome and type 2 diabetes mellitus, Diabetes, Obesity and Metabolism, 2012, 14, 10
  13. You have free access to this content13
    Dennis R. Trune, Barbara Canlon, Corticosteroid Therapy for Hearing and Balance Disorders, The Anatomical Record, 2012, 295, 11
  14. 14
    Guido Di Dalmazi, Uberto Pagotto, Renato Pasquali, Valentina Vicennati, Glucocorticoids and Type 2 Diabetes: From Physiology to Pathology, Journal of Nutrition and Metabolism, 2012, 2012, 1

    CrossRef

  15. 15
    M.A. Martínez-García, J.L. San-Millán, H.F. Escobar-Morreale, The R453Q and D151A polymorphisms of Hexose-6-Phosphate Dehydrogenase Gene (H6PD) influence the polycystic ovary syndrome (PCOS) and obesity, Gene, 2012, 497, 1, 38

    CrossRef

  16. 16
    Vincenzo Marzolla, Andrea Armani, Maria-Christina Zennaro, Francesca Cinti, Caterina Mammi, Andrea Fabbri, Giuseppe M.C. Rosano, Massimiliano Caprio, The role of the mineralocorticoid receptor in adipocyte biology and fat metabolism, Molecular and Cellular Endocrinology, 2012, 350, 2, 281

    CrossRef

  17. 17
    M. M. Molusky, S. Li, D. Ma, L. Yu, J. D. Lin, Ubiquitin-Specific Protease 2 Regulates Hepatic Gluconeogenesis and Diurnal Glucose Metabolism Through 11 -Hydroxysteroid Dehydrogenase 1, Diabetes, 2012, 61, 5, 1025

    CrossRef

  18. 18
    Caitlin S. Wyrwoll, Megan C. Holmes, Jonathan R. Seckl, 11β-Hydroxysteroid dehydrogenases and the brain: From zero to hero, a decade of progress, Frontiers in Neuroendocrinology, 2011, 32, 3, 265

    CrossRef

  19. 19
    Tomasz Sledzinski, Jacek Turyn, Ewa Stelmanska, Malgorzata Presler, Jerzy Klimek, Julian Swierczynski, Chronic food restriction up-regulates 11-β-hydroxysteroid dehydrogenase, Open Life Sciences, 2011, 6, 3

    CrossRef

  20. 20
    Shengxian Li, Wei Liu, Lihua Wang, Rong Huang, Qi Chen, Yihua Wu, Yiting Cai, Effects of menopause on hepatic 11β-hydroxysteroid dehydrogenase type 1 activity and adrenal sensitivity to adrenocorticotropin in healthy non-obese women, Gynecological Endocrinology, 2011, 27, 10, 794

    CrossRef

  21. 21
    Haixia Wang, Jeffrey A. Robl, Lawrence G. Hamann, Ligaya Simpkins, Rajasree Golla, Yi-Xin Li, Ramakrishna Seethala, Tatyana Zvyaga, David A. Gordon, James J. Li, Generation of 3,8-substituted 1,2,4-triazolopyridines as potent inhibitors of human 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD-1), Bioorganic & Medicinal Chemistry Letters, 2011, 21, 14, 4146

    CrossRef

  22. 22
    René Baudrand, José Miguel Domínguez, Cristian A. Carvajal, Arnoldo Riquelme, Carmen Campino, Stefano Macchiavello, Milan Bozinovic, Mauricio Morales, Margarita Pizarro, Nancy Solis, Alex Escalona, Camilo Boza, Marco Arrese, Carlos E. Fardella, Overexpression of hepatic 5α-reductase and 11β-hydroxysteroid dehydrogenase type 1 in visceral adipose tissue is associated with hyperinsulinemia in morbidly obese patients, Metabolism, 2011, 60, 12, 1775

    CrossRef

  23. 23
    Inna Meltser, Barbara Canlon, Protecting the auditory system with glucocorticoids, Hearing Research, 2011, 281, 1-2, 47

    CrossRef

  24. 24
    Zhenrong Xu, Colin M. Tice, Wei Zhao, Salvacion Cacatian, Yuan-Jie Ye, Suresh B. Singh, Peter Lindblom, Brian M. McKeever, Paula M. Krosky, Barbara A. Kruk, Jennifer Berbaum, Richard K. Harrison, Judith A. Johnson, Yuri Bukhtiyarov, Reshma Panemangalore, Boyd B. Scott, Yi Zhao, Joseph G. Bruno, Jennifer Togias, Joan Guo, Rong Guo, Patrick J. Carroll, Gerard M. McGeehan, Linghang Zhuang, Wei He, David A. Claremon, Structure-Based Design and Synthesis of 1,3-Oxazinan-2-one Inhibitors of 11β-Hydroxysteroid Dehydrogenase Type 1, Journal of Medicinal Chemistry, 2011, 54, 17, 6050

    CrossRef

  25. 25
    Ashley J. Peckett, David C. Wright, Michael C. Riddell, The effects of glucocorticoids on adipose tissue lipid metabolism, Metabolism, 2011, 60, 11, 1500

    CrossRef

  26. 26
    Emily Jane Gallagher, Derek LeRoith, Eddy Karnieli, The Metabolic Syndrome—from Insulin Resistance to Obesity and Diabetes, Medical Clinics of North America, 2011, 95, 5, 855

    CrossRef

  27. 27
    Claudia A. Staab, Edmund Maser, 11β-Hydroxysteroid dehydrogenase type 1 is an important regulator at the interface of obesity and inflammation, The Journal of Steroid Biochemistry and Molecular Biology, 2010, 119, 1-2, 56

    CrossRef

  28. 28
    Carmen Campino, Cristian A. Carvajal, Javiera Cornejo, Betty San Martín, Oliviero Olivieri, Giancesare Guidi, Giovanni Faccini, Francesco Pasini, Javiera Sateler, Rene Baudrand, Lorena Mosso, Gareth I. Owen, Alexis M. Kalergis, Oslando Padilla, Carlos E. Fardella, 11β-hydroxysteroid dehydrogenase type-2 and type-1 (11β-HSD2 and 11β-HSD1) and 5β-reductase activities in the pathogenia of essential hypertension, Endocrine, 2010, 37, 1, 106

    CrossRef

  29. 29
    Henry Bohler, Sriprakash Mokshagundam, Stephen J. Winters, Adipose tissue and reproduction in women, Fertility and Sterility, 2010, 94, 3, 795

    CrossRef

  30. 30
    Colin M. Tice, Wei Zhao, Paula M. Krosky, Barbara A. Kruk, Jennifer Berbaum, Judith A. Johnson, Yuri Bukhtiyarov, Reshma Panemangalore, Boyd B. Scott, Yi Zhao, Joseph G. Bruno, Lamont Howard, Jennifer Togias, Yuan-Jie Ye, Suresh B. Singh, Brian M. McKeever, Peter R. Lindblom, Joan Guo, Rong Guo, Herbert Nar, Annette Schuler-Metz, Richard E. Gregg, Katerina Leftheris, Richard K. Harrison, Gerard M. McGeehan, Linghang Zhuang, David A. Claremon, Discovery and optimization of adamantyl carbamate inhibitors of 11β-HSD1, Bioorganic & Medicinal Chemistry Letters, 2010, 20, 22, 6725

    CrossRef

  31. You have free access to this content31
    Tanya HYATT, Ruimin CHEN, Xudong WANG, Gail MICK, Kenneth MCCORMICK, Effect of diabetes on enzymes involved in rat hepatic corticosterone production, Journal of Diabetes, 2010, 2, 4
  32. 32
    Therése Andersson, Ingegerd Söderström, Kotryna Simonyté, Tommy Olsson, Estrogen Reduces 11β-Hydroxysteroid Dehydrogenase Type 1 in Liver and Visceral, but Not Subcutaneous, Adipose Tissue in Rats, Obesity, 2010, 18, 3
  33. 33
    René Baudrand, Cristian A. Carvajal, Arnoldo Riquelme, Mauricio Morales, Nancy Solis, Margarita Pizarro, Alex Escalona, Camilo Boza, Gustavo Pérez, Angélica Domínguez, Marco Arrese, Carlos E. Fardella, Overexpression of 11β-Hydroxysteroid Dehydrogenase Type 1 in Hepatic and Visceral Adipose Tissue is Associated with Metabolic Disorders in Morbidly Obese Patients, Obesity Surgery, 2010, 20, 1, 77

    CrossRef

  34. 34
    Adam J. Rose, Alexandros Vegiopoulos, Stephan Herzig, Role of glucocorticoids and the glucocorticoid receptor in metabolism: Insights from genetic manipulations, The Journal of Steroid Biochemistry and Molecular Biology, 2010, 122, 1-3, 10

    CrossRef

  35. 35
    Chi Hyun Kim, Young Sik Cho, Selection and optimization of MCF-7 cell line for screening selective inhibitors of 11β-hydroxysteroid dehydrogenase 2, Cell Biochemistry and Function, 2010, 28, 6
  36. 36
    Colin M. Tice, Wei Zhao, Zhenrong Xu, Salvacion T. Cacatian, Robert D. Simpson, Yuan-Jie Ye, Suresh B. Singh, Brian M. McKeever, Peter Lindblom, Joan Guo, Paula M. Krosky, Barbara A. Kruk, Jennifer Berbaum, Richard K. Harrison, Judith J. Johnson, Yuri Bukhtiyarov, Reshma Panemangalore, Boyd B. Scott, Yi Zhao, Joseph G. Bruno, Linghang Zhuang, Gerard M. McGeehan, Wei He, David A. Claremon, Spirocyclic ureas: Orally bioavailable 11β-HSD1 inhibitors identified by computer-aided drug design, Bioorganic & Medicinal Chemistry Letters, 2010, 20, 3, 881

    CrossRef

  37. 37
    M. E. Holmes, P. Ekkekakis, J. C. Eisenmann, The physical activity, stress and metabolic syndrome triangle: a guide to unfamiliar territory for the obesity researcher, Obesity Reviews, 2010, 11, 7
  38. 38
    B. Robinzon, R.A. Prough, A novel NADP+-dependent dehydrogenase activity for 7α/β- and 11β-hydroxysteroids in human liver nuclei: A third 11β-hydroxysteroid dehydrogenase, Archives of Biochemistry and Biophysics, 2009, 486, 2, 170

    CrossRef

  39. 39
    Ming Zhang, Xiao-Yan Lv, Jing Li, Zhi-Gang Xu, Li Chen, Alteration of 11β-hydroxysteroid dehydrogenase type 1 in skeletal muscle in a rat model of type 2 diabetes, Molecular and Cellular Biochemistry, 2009, 324, 1-2, 147

    CrossRef

  40. 40
    Karine Blouin, Alain Veilleux, Van Luu-The, André Tchernof, Androgen metabolism in adipose tissue: Recent advances, Molecular and Cellular Endocrinology, 2009, 301, 1-2, 97

    CrossRef

  41. 41
    A. Hirata, N. Maeda, A. Hiuge, T. Hibuse, K. Fujita, T. Okada, S. Kihara, T. Funahashi, I. Shimomura, Blockade of mineralocorticoid receptor reverses adipocyte dysfunction and insulin resistance in obese mice, Cardiovascular Research, 2009, 84, 1, 164

    CrossRef

  42. 42
    Yan-ling Zhang, Xiaotian Zhong, Zheni Gjoka, Yuanhong Li, Wayne Stochaj, Mark Stahl, Ron Kriz, James F. Tobin, David Erbe, Vipin Suri, H6PDH interacts directly with 11β-HSD1: Implications for determining the directionality of glucocorticoid catalysis, Archives of Biochemistry and Biophysics, 2009, 483, 1, 45

    CrossRef

  43. 43
    A. Iovino, A.J. Scheen, La 11β-hydroxystéroïde déshydrogénase de type 1 – 1re partie, Médecine des Maladies Métaboliques, 2009, 3, 5, 507

    CrossRef

  44. 44
    A. Iovino, A.J. Scheen, La 11β-hydroxystéroïde déshydrogénase de type 1 – 2e partie Inhibition sélective pour traiter les anomalies métaboliques associées à l’obésité, Médecine des Maladies Métaboliques, 2009, 3, 6, 595

    CrossRef

  45. 45
    Alain Veilleux, Karine Blouin, André Tchernof, Mechanisms of androgenic action in adipose tissue, Clinical Lipidology, 2009, 4, 3, 367

    CrossRef

  46. 46
    Coleman Gross, Christine M. Blasey, Robert L. Roe, Kate Allen, Thaddeus S. Block, Joseph K. Belanoff, Mifepristone treatment of olanzapine-induced weight gain in healthy men, Advances in Therapy, 2009, 26, 10, 959

    CrossRef

  47. 47
    Zdenka Zemanova, Miluse Strnadova, Zuzana Jirsova, Petra Klusonova, Occurrence of lipids in the liver of the hypertriglyceridemic rats, Biomedical Papers, 2009, 153, 1, 37

    CrossRef

  48. 48
    A. Iovino, N. Paquot, A.J. Scheen, Rôle de l’enzyme 11β-hydroxystéroïde-déshydrogénase de type 1 dans le risque métabolique associé à l’obésité, Obésité, 2009, 4, 3-4, 181

    CrossRef

  49. 49
    Katherine A Hughes, Scott P Webster, Brian R Walker, 11-Beta-hydroxysteroid dehydrogenase type 1 (11β-HSD1) inhibitors in Type 2 diabetes mellitus and obesity, Expert Opinion on Investigational Drugs, 2008, 17, 4, 481

    CrossRef

  50. 50
    Maise Al Bakir, Asif N. Butt, R. Swaminathan, Circulating 11β-Hydroxysteroid Dehydrogenase Type 1 mRNA and Cardiovascular Risk Factors, Annals of the New York Academy of Sciences, 2008, 1137, 1
  51. 51
    A. Katz, R. Heiblum, R. Meidan, B. Robinzon, Corticosterone oxidative neutralization by 11-β hydroxysteroid dehydrogenases in kidney and colon of the domestic fowl, General and Comparative Endocrinology, 2008, 155, 3, 814

    CrossRef

  52. 52
    M. Wabitsch, P. Fischer-Posovszky, Grundlagen der Fettgewebsforschung und Adipozytokine, Gynäkologische Endokrinologie, 2008, 6, 1, 6

    CrossRef

  53. 53
    Eun Kyung Lee, Young Joo Park, Metabolic Regulation of Nuclear Receptors, Journal of Korean Endocrine Society, 2008, 23, 3, 155

    CrossRef

  54. 54
    Junichiro Sonoda, Liming Pei, Ronald M. Evans, Nuclear receptors: Decoding metabolic disease, FEBS Letters, 2008, 582, 1, 2

    CrossRef

  55. 55
    Ashley Taylor, Nigel Irwin, Aine M. McKillop, Peter R. Flatt, Victor A. Gault, Sub-chronic administration of the 11β-HSD1 inhibitor, carbenoxolone, improves glucose tolerance and insulin sensitivity in mice with diet-induced obesity, Biological Chemistry, 2008, 389, 4

    CrossRef

  56. 56
    E. Beck, N. Paquot, A. J. Scheen, Sujets « métaboliquement obèses » de poids normal. Première partie: diagnostic, physiopathologie et prévalence, Obésité, 2008, 3, 3, 184

    CrossRef

  57. 57
    Emily Jane Gallagher, Derek LeRoith, Eddy Karnieli, The Metabolic Syndrome—from Insulin Resistance to Obesity and Diabetes, Endocrinology and Metabolism Clinics of North America, 2008, 37, 3, 559

    CrossRef

  58. 58
    Katherine L. Gross, John A. Cidlowski, Tissue-specific glucocorticoid action: a family affair, Trends in Endocrinology & Metabolism, 2008, 19, 9, 331

    CrossRef

  59. 59
    Alexandros Vegiopoulos, Stephan Herzig, Glucocorticoids, metabolism and metabolic diseases, Molecular and Cellular Endocrinology, 2007, 275, 1-2, 43

    CrossRef

  60. You have free access to this content60
    Poorna R. Karuparthi, Preethi Yerram, Diptesh Gupta, High-Cortisol States Can Masquerade as the Cardiometabolic Syndrome, Journal of the CardioMetabolic Syndrome, 2007, 2, 3
  61. 61
    Nicole Gallo-Payet, Marie-Claude Battista, Steroidogenesis—Adrenal Cell Signal Transduction, Comprehensive Physiology,